Di-(2-ethylhexyl) Phthalate Exposure Induces Developmental Toxicity in the Mouse Fetal Heart via Mitochondrial Dysfunction

Cardiovasc Toxicol. 2025 Jan;25(1):48-57. doi: 10.1007/s12012-024-09936-4. Epub 2024 Oct 25.

Abstract

Congenital heart disease (CHD) is a major cause of infant mortality and morbidity, with growing interest in the role of environmental factors in its etiology. Di-(2-ethylhexyl) phthalate (DEHP), an environmental endocrine disruptor, has been implicated in the development of CHD. This study aimed to investigate the effects of DEHP exposure on fetal heart development in mice. Pregnant mice exposed to DEHP exhibited increased fetal malformations, decreased fetal weight, and reduced crown-rump length.f Transcriptomic analysis revealed the downregulation of genes involved in aerobic respiration and mitochondrial ATP synthesis. Functional assays demonstrated reduced mitochondrial respiration, decreased ATP production, elevated reactive oxygen species levels, and lowered mitochondrial membrane potential in DEHP-exposed fetal cardiomyocytes. These findings underscore the detrimental effects of DEHP on fetal cardiac health and provide insights into the molecular mechanisms underlying DEHP-induced CHD. Understanding these mechanisms is crucial for developing preventive strategies against environmental toxicants that affect fetal cardiac development.

Keywords: Congenital heart disease; DEHP; Mitochondrial dysfunction; Oxidative stress.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Cardiotoxicity
  • Cells, Cultured
  • Diethylhexyl Phthalate* / toxicity
  • Endocrine Disruptors* / toxicity
  • Energy Metabolism / drug effects
  • Female
  • Fetal Heart* / drug effects
  • Fetal Heart* / metabolism
  • Fetal Heart* / pathology
  • Gene Expression Regulation, Developmental* / drug effects
  • Gestational Age
  • Heart Defects, Congenital / chemically induced
  • Heart Defects, Congenital / genetics
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / pathology
  • Heart Defects, Congenital / physiopathology
  • Male
  • Maternal Exposure
  • Membrane Potential, Mitochondrial* / drug effects
  • Mice
  • Mitochondria, Heart* / drug effects
  • Mitochondria, Heart* / metabolism
  • Mitochondria, Heart* / pathology
  • Myocytes, Cardiac* / drug effects
  • Myocytes, Cardiac* / metabolism
  • Myocytes, Cardiac* / pathology
  • Oxidative Stress / drug effects
  • Plasticizers / toxicity
  • Pregnancy
  • Reactive Oxygen Species / metabolism
  • Transcriptome

Substances

  • Diethylhexyl Phthalate
  • Endocrine Disruptors
  • Reactive Oxygen Species
  • Adenosine Triphosphate
  • Plasticizers